EUVIMEDEUVIMED entdecken
Kommentar

Risk Stratification in Steatotic Liver Disease

Melinda Wang

JAMA Internal Medicine · 01.11.2026 · 186 (11) · 1367

DOI: 10.1001/jamainternmed.2026.4120 ↗

Kurz gefasst

Kommentar in der Zeitschrift JAMA Internal Medicine, erschienen am 01.11.2026. Verfasst von Melinda Wang. Beteiligte Einrichtung: Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of California, San Francisco. Die Arbeit nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of California, San Francisco.

Zitieren

APA

Wang, M. (2026). Risk Stratification in Steatotic Liver Disease. JAMA Internal Medicine, 186(11), 1367. https://doi.org/10.1001/jamainternmed.2026.4120

Vancouver

Wang M. Risk Stratification in Steatotic Liver Disease. JAMA Internal Medicine. 2026;186(11):1367. doi:10.1001/jamainternmed.2026.4120

BibTeX
@article{Wang2026,
  author = {Wang, Melinda},
  title = {Risk Stratification in Steatotic Liver Disease},
  journal = {JAMA Internal Medicine},
  year = {2026},
  volume = {186},
  number = {11},
  pages = {1367},
  doi = {10.1001/jamainternmed.2026.4120}
}
Kostenlos starten →